NewDelhi: CDSCO has disclosed findings from December drug tests demonstrating that more than 135 drug samples failed to match required quality benchmarks. Medications that treat cardiac diseases, diabetes conditions, kidney problems, blood pressure disorders as well as antibiotics make up this list of understood drugs.
Drug quality test failures have maintained steady occurrence throughout the past several months and several pharmaceutical giants in India produce these deficient drugs. The defective drugs that failed quality tests received a classification indicating they are hazardous to health.
Regulatory bodies turned their attention toward these drug manufacturers as the manufacturers faced investigation. Failed drugs primarily target diabetes and migraine treatments. State drug testing labs reported 84 substandard samples compared to Central labs which noted 51. Regulatory authorities have started the licence revocation for these problematic drug manufacturers.
The list of failed drugs includes various antibiotics supplied by Jan Aushadhi Kendras, like Cefpodoxime Tablet IP 200 mg besides Divalproex Extended-Release Tablet alongside metFORMIN Hydrochloride IDE Tablet with Zinc Sulphate Tablet, yet metFORMIN Tablet 500 mg, then Amoximoon CV-625 and the Paracetamol 500 mg option.
The list of significant generic drugs contains Beta Histine by CMG Biotech in addition to Okamet by Cipla and Pantaprazole produced by Admad Pharma together with Amoxicillin manufactured by VedSP Pharma and Shamshree Lifesciences’ Meropenem Injection-500 along with Orison Pharma’s Telmisartan as well as Albendazole by Martin & Brown.
The government implemented a ban on multiple pharmaceuticals while specifically targeting a group of 206 fixed-dose combination medications considered detrimental to health. FDC drugs deliver instant relief by packing multiple medications within a single pill. Analyses revealed 135 drug failures which pushed the count of below-standard medicines beyond 300 in total numbers.
CDSCO relies on intensive quality testing procedures to assess medications’ safety and effectiveness for maintaining drug quality standards. Quality testers cheque documents and examine expiry dates along with the product labelling. The agency verifies any incorrect data while correcting labelling mistakes.
Comments are closed.